AUA Capital Management’s Novartis NVS Stock Holding History

AUA Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-98	Closed	-$9K	–	346
2020 Q2	$9K	Hold	98	–	–	0.01%	143
2020 Q1	$8K	Hold	98	–	–	0.01%	159
2019 Q4	$9K	Hold	98	–	–	0.01%	162
2019 Q3	$9K	Hold	98	–	–	0.01%	165
2019 Q2	$9K	Sell	98 -11	-10%	-$931	0.01%	165
2019 Q1	$9K	Hold	109	–	–	0.01%	163
2018 Q4	$8K	Hold	109	–	–	0.01%	161
2018 Q3	$8K	Hold	109	–	–	0.01%	169
2018 Q2	$7K	Hold	109	–	–	0.01%	171
2018 Q1	$8K	Hold	109	–	–	0.01%	183
2017 Q4	$8K	Hold	109	–	–	0.01%	194
2017 Q3	$8K	Hold	109	–	–	0.01%	191
2017 Q2	$8K	Buy	+109	New	+$7.72K	0.01%	190
2017 Q1	–	Sell	-109	Closed	-$7K	–	203
2016 Q4	$7K	Buy	+109	New	+$7.07K	0.01%	186

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AUA Capital Management's NVS Position: Q3 2020 in Review

AUA Capital Management sold out of Novartis (NVS) in Q3 2020, closing a stake of 98 shares — an estimated $9K sold.

AUA Capital Management first reported a position in NVS in Q4 2016 and held it in 14 quarters. The position peaked at $9K in Q2 2020. 1,118 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

AUA Capital Management reported no remaining Novartis position as of Q3 2020 after selling out during the quarter.
AUA Capital Management sold 98 Novartis shares in Q3 2020, an estimated $9K.
AUA Capital Management first reported a position in Novartis in Q4 2016 and held it in 14 quarters.
AUA Capital Management's Novartis position peaked at $9K in Q2 2020.
1,118 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on AUA Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.